Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
NAGA (gene)
Introduction
Alpha-N-acetylgalactosaminidase is an enzyme that in humans is encoded by the NAGA gene.[1]
NAGA encodes the lysosomal enzyme alpha-N-acetylgalactosaminidase, which cleaves alpha-N-acetylgalactosaminyl moieties from glycoconjugates. Mutations in NAGA have been identified as the cause of Schindler disease types I and II (type II also known as Kanzaki disease).[1]
Further reading
Further reading
- Cantz M, Ulrich-Bott B (1990). “Disorders of glycoprotein degradation”. J. Inherit. Metab. Dis. 13 (4): 523–37. doi:10.1007/BF01799510. PMID 2122119.
- Wang AM, Desnick RJ (1991). “Structural organization and complete sequence of the human alpha-N-acetylgalactosaminidase gene: homology with the alpha-galactosidase A gene provides evidence for evolution from a common ancestral gene”. Genomics. 10 (1): 133–42. doi:10.1016/0888-7543(91)90493-X. PMID 1646157.
- Wang AM, Bishop DF, Desnick RJ (1991). “Human alpha-N-acetylgalactosaminidase-molecular cloning, nucleotide sequence, and expression of a full-length cDNA. Homology with human alpha-galactosidase A suggests evolution from a common ancestral gene”. J. Biol. Chem. 265 (35): 21859–66. PMID 2174888.
- Wang AM, Schindler D, Desnick R (1990). “Schindler disease: the molecular lesion in the alpha-N-acetylgalactosaminidase gene that causes an infantile neuroaxonal dystrophy”. J. Clin. Invest. 86 (5): 1752–6. doi:10.1172/JCI114901. PMC 296929. PMID 2243144.
- Warner TG, Louie A, Potier M (1991). “Photolabeling of the alpha-neuraminidase/beta-galactosidase complex from human placenta with a photoreactive neuraminidase inhibitor”. Biochem. Biophys. Res. Commun. 173 (1): 13–9. doi:10.1016/S0006-291X(05)81014-9. PMID 2256909.
- Yamauchi T, Hiraiwa M, Kobayashi H, et al. (1990). “Molecular cloning of two species of cDNAs for human alpha-N-acetylgalactosaminidase and expression in mammalian cells”. Biochem. Biophys. Res. Commun. 170 (1): 231–7. doi:10.1016/0006-291X(90)91264-S. PMID 2372288.
- Tsuji S, Yamauchi T, Hiraiwa M, et al. (1989). “Molecular cloning of a full-length cDNA for human alpha-N-acetylgalactosaminidase (alpha-galactosidase B)”. Biochem. Biophys. Res. Commun. 163 (3): 1498–504. doi:10.1016/0006-291X(89)91149-2. PMID 2551294.
- Chabás A, Coll MJ, Aparicio M, Rodriguez Diaz E (1995). “Mild phenotypic expression of alpha-N-acetylgalactosaminidase deficiency in two adult siblings”. J. Inherit. Metab. Dis. 17 (6): 724–31. doi:10.1007/BF00712015. PMID 7707696.
- Wang AM, Kanzaki T, Desnick RJ (1994). “The molecular lesion in the alpha-N-acetylgalactosaminidase gene that causes angiokeratoma corporis diffusum with glycopeptiduria”. J. Clin. Invest. 94 (2): 839–45. doi:10.1172/JCI117404. PMC 296165. PMID 8040340.
- de Jong J, van den Berg C, Wijburg H, et al. (1994). “alpha-N-acetylgalactosaminidase deficiency with mild clinical manifestations and difficult biochemical diagnosis”. J. Pediatr. 125 (3): 385–91. doi:10.1016/S0022-3476(05)83281-0. PMID 8071745.
- Keulemans JL, Reuser AJ, Kroos MA, et al. (1996). “Human alpha-N-acetylgalactosaminidase (alpha-NAGA) deficiency: new mutations and the paradox between genotype and phenotype”. J. Med. Genet. 33 (6): 458–64. doi:10.1136/jmg.33.6.458. PMC 1050630. PMID 8782044.
- Den Tandt WR, Scharpé S (1997). “Micromethod for the fluorimetric determination of plasma N-acetyl-alpha-D-galactosaminidase and study of some of its characteristics”. Enzyme Protein. 49 (5–6): 273–80. PMID 9252785.
- Gaudet R, Savage JR, McLaughlin JN, et al. (1999). “A molecular mechanism for the phosphorylation-dependent regulation of heterotrimeric G proteins by phosducin”. Mol. Cell. 3 (5): 649–60. doi:10.1016/S1097-2765(00)80358-5. PMID 10360181.
- Dunham I, Shimizu N, Roe BA, et al. (1999). “The DNA sequence of human chromosome 22”. Nature. 402 (6761): 489–95. doi:10.1038/990031. PMID 10591208.
- Ohta M, Ohnishi T, Ioannou YA, et al. (2000). “Human alpha-N-acetylgalactosaminidase: site occupancy and structure of N-linked oligosaccharides”. Glycobiology. 10 (3): 251–61. doi:10.1093/glycob/10.3.251. PMID 10704524.
- Kodama K, Kobayashi H, Abe R, et al. (2001). “A new case of alpha-N-acetylgalactosaminidase deficiency with angiokeratoma corporis diffusum, with Ménière’s syndrome and without mental retardation”. Br. J. Dermatol. 144 (2): 363–8. doi:10.1046/j.1365-2133.2001.04028.x. PMID 11251574.
- Mohamad SB, Nagasawa H, Uto Y, Hori H (2003). “Tumor cell alpha-N-acetylgalactosaminidase activity and its involvement in GcMAF-related macrophage activation”. Comp. Biochem. Physiol., Part a Mol. Integr. Physiol. 132 (1): 1–8. doi:10.1016/S1095-6433(01)00522-0. PMID 12062184.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). “Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences”. Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Collins JE, Wright CL, Edwards CA, et al. (2005). “A genome annotation-driven approach to cloning the human ORFeome”. Genome Biol. 5 (10): R84. doi:10.1186/gb-2004-5-10-r84. PMCÂ 545604. PMIDÂ 15461802.